Patient Outcomes Following Total Joint Replacement Surgery: A Comparison of Hospitals and Ambulatory Surgery Centers
Patient Outcomes Following Total Joint Replacement Surgery: A Comparison of Hospitals and Ambulatory Surgery Centers
批准号:
9896744
负责人:
Kathleen Carey
金额:
$8.25万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-04-01 至 2020-12-31
关键词:
Ambulatory Surgical ProceduresAreaBusinessesCaringCategoriesCessation of lifeComplexDataDeep Vein ThrombosisDiagnosis-Related GroupsDislocationsEnrollmentExpenditureFrightHealthHealth systemHospitalsInpatientsInterventionMeasuresMedicareModelingOperative Surgical ProceduresOutcomeOutpatientsPatient-Focused OutcomesPatientsPhysiciansPoliciesPopulationPostoperative ComplicationsPrivatizationProceduresProsthesisProviderPulmonary EmbolismReplacement ArthroplastyResearchResourcesRiskRisk AdjustmentSamplingServicesSiteSurgical Wound InfectionTechniquesTestingTimebasebeneficiarycare deliverycare episodedesignhigh riskhip replacement arthroplastyhospital readmissionknee replacement arthroplastymedical specialtiesmigrationolder patientoutpatient facilitypatient engagementpatient safetypaymentrelative cost
中文摘要
项目摘要/摘要
CMS最近开始为#年进行的全膝关节置换手术(关节成形术;TKA)买单
医院门诊部(HOPD),并正在考虑报销HOPD全髋关节
关节成形术(THA)许多观察人士预计,医疗保险将在门诊为TKA和THA支付费用
手术中心(ASC)紧随其后。目前,正在进行全关节置换
在HOPD和越来越多的ASC中有商业保险的患者。然而,尽管
ASCS的医生所有者声称门诊全关节置换术是合适的,
对于大部分候选人来说,迄今为止的证据是基于一组有限的研究,这些研究使用的是
在HOPD接受治疗的患者样本非常少。随着ASCs稳步扩大其
商业和越来越复杂的手术,一些专家担心他们忽略了高风险
健康问题。然而,有可能在减少依赖的情况下取得类似的结果。
关于传统卫生系统资源的问题。在美国,大多数关节置换接受者。
是联邦医疗保险受益人,这一人群中门诊TKA的结果数据将不会
在一段时间内可用。在此期间,我们建议比较TKA和THA的结果,并
在住院患者、HOPD和ASC设置中使用大量商业-
有保险的病人。我们将确定接受全膝关节置换术或全髋关节置换术的老年患者
2014-2019年住院或门诊ASC设置,并连续参加
手术后90天。我们将选择住院患者的匹配样本,HOPD
以及使用倾向分数技术的ASC设置,与以下项生成的风险分数匹配
HHS分级条件分类风险调整模型的设计
适用于商业保险人群的ACA。我们将确定以下情况
相关的30天和90天再次住院,以及翻修手术后90天内的病例,外科手术
部位感染、深静脉血栓形成、肺栓塞和脱位/松动/断裂
假肢。我们将使用统计技术测试不同站点之间的差异。最后,我们会
衡量护理事件的相对成本,包括在
住院后90天住院或ASC遭遇。这个项目将启发CMS的潜力
进一步过渡到门诊手术的健康后果。对于提供商,它将标识
潜在患者安全失误的领域,以及干预的目标。最后,它将促进
通过告知门诊关节的“灰色区域”候选人,让患者参与到护理中来
替代者在做出关于在哪里接受手术的更明智的决定方面。
英文摘要
Project Summary/Abstract
CMS recently began paying for total knee replacement surgery (arthroplasty; TKA) performed in
hospital outpatient departments (HOPDs) and is considering reimbursing for HOPD total hip
arthroplasty (THA). Many observers expect Medicare payment for TKA and THA in ambulatory
surgery centers (ASCs) to follow. Currently, total joint replacements are being performed on
commercially insured patients in HOPDs and in a growing number of ASCs. However, despite
claims by physician-owners of ASCs that outpatient total joint replacement is appropriate and
safe for a large portion of candidates, evidence to date is based on a limited set of studies using
very small samples of patients treated in HOPDs. As ASCs have steadily expanded their
business and taken on increasingly complex surgeries, some experts fear they overlook high-risk
health problems. Yet it is possible that comparable outcomes can be achieved with less reliance
on traditional health system resources. The majority of joint replacement recipients in the U.S.
are Medicare beneficiaries, and outcomes data on outpatient TKA in this population will not be
available for some time. In the interim, we propose to compare TKA and THA outcomes and
payments across inpatient, HOPD, and ASC settings using a large sample of commercially-
insured patients. We will identify near elderly patients who underwent TKA or THA in an
inpatient or outpatient ASC setting during 2014-2019 and who were continuously enrolled for
90 days following surgery. We will select matched samples of patients across inpatient, HOPD
and ASC settings using propensity score techniques, matching with risk scores generated from
the HHS Hierarchical Condition Categories risk adjustment model which was designed under
the ACA for application to the commercially-insured population. We will identify cases of
related 30-day and 90-day readmission, and cases within 90-days of revision surgery, surgical
site infection, deep-vein thrombosis, pulmonary embolism, and dislocation/loosening/breakage
of prosthesis. We will test differences across sites using statistical techniques. Finally, we will
measure the relative cost of episodes of care including related expenditures incurred during the
90-day post-inpatient stay or ASC encounter. This project will enlighten CMS on potential
health consequences of further transitions to outpatient surgery. For providers, it will identify
areas of potential patient safety lapses, and targets for interventions. Finally, it will facilitate
patient engagement in their care by informing “gray area” candidates for outpatient joint
replacement in making wiser decisions about where to undergo surgery.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Behavioral Health Integration in Community Health Centers and Hospital Emergency Department Utilization
-
批准号:10364901
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2022
-
负责人:Kathleen Carey
-
依托单位:
Safety-Net Hospitals Under Mandatory Bundled Payment
-
批准号:10296964
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2021
-
负责人:Kathleen Carey
-
依托单位:
Profiling Improvement under the Hospital Readmissions Reduction Program
-
批准号:9181045
-
项目类别:
-
资助金额:$9.96万
-
财政年份:2016
-
负责人:Kathleen Carey
-
依托单位:
The Impact of CMS Public Reports of Hospital Charge Data
-
批准号:9244429
-
项目类别:
-
资助金额:$9.98万
-
财政年份:2016
-
负责人:Kathleen Carey
-
依托单位:
An Investigation into Hospital Lengths of Stay and Costly Readmissions
-
批准号:8228864
-
项目类别:
-
资助金额:$9.96万
-
财政年份:2011
-
负责人:Kathleen Carey
-
依托单位:
Inpatient Safety and Costs in U.S. Hospitals
-
批准号:7589398
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2009
-
负责人:Kathleen Carey
-
依托单位:
The Effects of Single Specialty Hospital Entry on Hospital Market Competition
-
批准号:7215409
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2006
-
负责人:Kathleen Carey
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: